Stay updated on Batoclimab in Myasthenia Gravis: Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.

Latest updates to the Batoclimab in Myasthenia Gravis: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the phase 3 batoclimab study in adults with generalized myasthenia gravis, including its study design, eligibility criteria, locations, and outcome measures, instead of a 403 error.SummaryDifference86%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about a transition, including a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe site revision displayed in the footer changed from v3.7.1 to v3.7.2; the page remains a 403 error page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content and displaying the site header/footer, effectively blocking access to the study record.SummaryDifference17%

Stay in the know with updates to Batoclimab in Myasthenia Gravis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Myasthenia Gravis: Clinical Trial page.